1. Two carbons, carbon-2 and one of carbons-3 to -5, of lysine seemed likely to be incorporated into one of carbon of the chromophore moiety of formycin.
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2. From the results of radioisotopic studies with glutamate, r-amino-n-butyrate or organic acids related to tricarboxylic acid cycle, the important role of glutamate in the biosynthesis of formycin was strongly suggested.
3. The incorporation of nitrogen(s) of lysine into three nitrogens, including two nitrogens of pyrazole ring, of formycin was suggested by mass spectroscopy. 4 . Ribose was estimated as a direct precursor for the ribosyl moiety of formycin, whereas the biosynthesis of ribose was shown to occur via the pathway other than hexose monophosphate shunt or glucuronate pathway.
5. In replacement culture, the salvage synthesis of formycin from its chromophore moiety was not observed and it was also evident that the chromophore moiety or pyrazofurin (pyrazomycin) inhibited the biosynthesis of formycin.
There have been several investigations on the biosynthesis of C-riboside nucleosides, i.e., pseudouridine, showdomycin, minimycin, pyrazofurin (pyrazomycin) and the formycin family. In the biosynthesis of pseudouridine, the intramolecular rearrangement in tRNA of uridylate to pseudouridylate has been strongly suggested.1-6) The biosynthesis of showdomycin has been well established and confirmed to occur by the condensation of ribose and an asymmetric four-carbon dicaboxylic acid. [7] [8] [9] [10] Recently, studies on the biosynthesis of minimycin revealed a novel mechanism whereby C-riboside linkage is formed from sedoheptulose 7-phosphate (or eight-carbon branched chain sugar phosphate).11)
C-Riboside linkage of pyrazofurin was also believed to be formed by this mechanism.11)
The biosynthesis of formycin by Nocardia interforma has been proposed to occur via a pathway other than that of biosynthesis of purine nucleotide while exogeneously added ribose was estimated to be incorporated into the ribosyl moiety of formycin.12) It was also reported that formycin may be formed from formycin 5'-monophosphate then deaminated to formycin B.13) Using Streptomyces sp.
MA406-A-1, a formycin-producing strain, we reported that carbon atom from lysine, glutamate and/or aspartate was incorporated into formycin with high efficiency, and that novel enzyme(s) catalyzing the amination of formycin B to formycin was present in this organism. 14,15) To elucidate the more detailed mechanism of formycin biosynthesis, we examined the incorporation and the distribution of various labeled compounds into formycin and this paper presents the results of these studies. 
Materials and Methods
Organisms and Cultivation Streptomyces sp. MA406-A-1 and Xanthomonas oryzae were obtained from the Institute of Microbial Chemistry, Tokyo. Cultivation of the Streptomycete was carried out for 1012 hours in a maltosepeptone-yeast extract medium (MPY-medium) and the washed cells prepared from the cultured broth were used in the replacement culture at 27°C with 50 ml of glucose-lysine-NH,Cl medium (GL-medium) as previously described 14). When 14C-labeled compounds were used in the experiments, 5 pCi of each compound were added to 50 ml of GL-medium with exception of adding 10 pCi of DL-lysine.
Degradation of Formycin 7-Amino-3-carboxypyrazolo [4,3- One gram of formycin was dissolved in 100 ml of 6 % sodium periodate and the solution was kept for a week at 0'5°C.
Pale yellowish precipitates that formed were collected on a glass filter (G-4) and dried at room temperature to yield 300 mg of amorphous powder (7-amino-3-aldehyde-pyrazolo- [4,3-d] pyrimidine, DFA-1). DFA-1 (300 mg) was dissolved in 30 ml of 0.1 N NaOH on a boiling waterbath and allowed to stand for 2-3 days at room temperature. The crystals usually appeared though in certain cases, the crystals did not appear. The crystals were dissolved on a boiling water-bath and the pH value of the warm solution was adjusted to 5.0 with 2 N HCl. After keeping the acidified solution overnight at O-5°C, the precipitates that formed were collected and dried at room temperature to yield 200 mg of pale yellowish powder (DFA-3). DFA-3 (200 mg) thus prepared was mixed with 20 ml of quinoline and 20 mg of copper powder and reflexed for 1 hour. After filtration, the filtrate was mixed with 80 ml of benzene and 20 ml of 0.1 N NaOH and the mixture was shaken vigorously. After discarding the benzene layer, the water layer was washed twice with 40 ml each of benzene and adjusted to give pH 6 to 7 with 2 N HCl. The aqueous solution was applied on a column (¢1 cm x 8 cm) of active charcoal and the column was washed with 30 ml of water. The column was eluted with 50 % aqueous acetone and the eluate was cut into 5-ml fractions. The appropriate fractions showing maximum absorption at 291 nm were pooled and evaporated in vacuo at 40°C to yield 58 mg of white powder (DFA-4). Fig. I shows the ultraviolet spectra of DFA-3 and -4 in 0.1 N NaOH and these spectra coincided with those observed by Dr. KAWAMURA (personal communications). Melting points of DFA-3 and -4 were identical with those reported.16) From NMR spectra and mass spectrometries, it was also confirmed that DFA-3 and -4 were identical with 7-amino-3-carboxypyrazolo [4,3- oryzae as a test organism. As previously reported, specific radioactivity of formycin was calculated after the column chromatography with Dowex 1 x 4.14) For the degradation studies, the fractions containing formycin in the column chromatography were applied to a column (¢1 cm x 7 cm) of Dowex 50 W x 4 (200400 mesh) in the H+ form. After wasing with 50 ml of water, formycin was eluted with 0.1 N NH4OH and evaporated to dryness (white powder) in vacuo at 40°C. Formycin thus prepared was degradated to DFA-3 and -4, and when radioactive formycin was prepared, 100300 mg of nonradioactive authentic formycin were added as carrier in the degradation. Specific radioactivity of DFA-3 or -4 was determined by measuring the radioactivity and concentration of these compounds in 0.1 N NaOH. The radioactivities were measured in a liquid scintillator reported previously. 14) The concentrations were calculated using the molar extinction coefficients (DFA-3, s306nm=8,410; DFA-4, s300nm=5,540) determined by KAWAMURA et al. 16) Resolution of DL-Lysine Chemical resolution of DL-lysine was carried out with DL-[2-14C]lysine and nonradioactive Lglutamate according to the method of EMMICK.17) The resolution product was identical with an authentic L-lysine-L-glutamate when compared by infrared spectrum and melting point.
Reagents and Analytical Measurements 16NH 4C1 was obtained from Stohler Isotope Chemicals Ltd. 14C-Labeled compounds were purchased from Daiichi Pure Chemicals Co., Ltd., and L-lysine-L-glutamate was from Sigma Chemical Co., Ltd. Pyrazofurin was kindly gifted by Dr. G. E. GUTOWSKI of the Lilly Research Laboratories. All other reagents were of analytical grade.
Ultraviolet spectra were obtained with a Hitachi spectrophotometer model 124. Radioactivities were measured in an Aloka liquid scintillation counter model LSC-502 using the liquid scintillator described previously.14) Infrared spectra were obtained by a Hitachi infrared spectrophotometer model EPI-S2 with KBr tablets. Mass spectra studies were done with a Hitachi mass spectrometer model RNS-4. NMR spectra were determined on a Hitachi NMR spectrometer (90 MHz).
Results

Incorporation and Distribution of 14C-Labeled Lysine into Formycin
Since our previous work suggested that lysine may be closely related to the biosynthesis of formycin,14) the distribution of 14C in formycin from [U-14C]lysine or [U-14C]glucose was examined in the replacement culture with GL-medium. Table I shows that 14C from lysine incorporated into formycin was exclusively located at the chromophore moiety of formycin (DFA-4) and about three-fourths of 14C from glucose were distributed in the ribosyl moiety . As shown in Table 2 , the ratios of the incorpo-
under the all experimental conditions examined. It was also confirmed that little or no radioactivity * Calculated as described in Table 1 . ** In experiment 1 , L-or DL-lysine was added at 10 or 20 mm, in experiment 2, L-or DLlysine was added at 2 or 4 mm, respectively.
In experiment 3 or 4, L-lysine was added at 20 or 5 mm, respectively. *** Experiment was not done . 
Incorporation and Distribution of 15N from 15NH4Cl into Formycin
To estimate which nitrogen source in GL-medium, lysine or NH4Cl, would function as nitrogen donor in the biosynthesis of formycin, 14NH4Cl was replaced by 15NH4Cl(95 atom %) and the replacement culture was carried out for 2 hours. Formycin accumulated was isolated and analyzed by mass spectroscopy on the basis of mass-spectral data presented by ToWNSEND and ROBINS.18) The spectra in Fig. 2 show that, when 15NH4Cl was used, the base peak observed at m/e 164 shifted to m/e 166 whereas peak at m/e 53 was not changed. The base peak (chromophore+30; diagnostic ion for Cribonucleoside) and peak at m/e 53 have been assigned as I and II (Fig. 2) , respectively.18)No or little formation of formycin was observed in the replacement culture with GL-medium from which lysine or NH4Cl was omitted. These results suggested that two nitrogens in aminopyrimidine moiety of formycin were derived from NH4Cl, so that, three nitrogens of formycin including two nitrogens in the pyrazole moiety were derived from nitrogen(s) of lysine. The shift of base peak to the peak at m/e 166 disappeared, as shown in Fig. 3 , in the experiment with use of GL-medium containing 15NH4Cl and supplemented glutamine or aspartate indicating the inhibition by these amino acids of the incorporation of 5N from 15NH4Cl into formycin. It was of interest that glutamine and/or aspartate also Table 1 . ** Experiment was not done.
done with the use of various labeled ribose and glucose. The data in Table 4 show that, although the incorporation of 14C from [U-14C]ribose into formycin was lower than that of 14C from [U-14C]glucose, almost 14C from [U-14 C] ribose was located at the ribosyl moiety of formycin and 18 % or 80 % of the radioactivity resided in carbon-1' or carbons-2' to -5' of the ribose, respectively. Moreover, 14C from [1-14C]ribose was exclusively located at carbon-i' of ribosyl moiety of formycin. These results suggested that ribose was the direct precursor for the ribosyl moiety of the antibiotic. It is of interest, however, that the incorporation efficiency of 14C from [1-14C]glucose into the ribosyl moiety was estimated to be similar to the efficiency of 14C from carbons-2 to -6 of glucose (in Table 4 
Discussion
From the data in Tables 1 and 2 , one carbon in the chromophore moiety of formycin can be estimated to be derived from two carbons (carbon-2 and one of carbons-3 to -5) of lysine. If this is true in this case, it may be possible to assume that the two carbons of lysine are incorporated into the chromophore moiety through symmetric intermediate including carbon-2 of lysine or an identical molecule formed from carbon-2 and one of carbons-3 to -5 of lysine. Although cadaverin, a related symmetric compound, has been known as a decarboxylated product of lysine, this compound seems unlikely to act as the symmetric intermediate by the following reasons. (1). Cadaverin could not substitute for lysine in formycin formation under the conditions of replacement culture. 14) (2). When carbon-2 of lysine is incorporated into formycin via cadaverin, carbon-6 of lysine should be also incorporated. However, as described in the text, 14C from [6-14C]lysine was not incorporated into formycin.
Incorporation-and distribution-patterns in Table 3 , which were obtained from the experiments with labeled glutamate and organic acids related to tricarboxylic acid cycle, are probably explained by the assumption that carbon(s) from these organic acids are incorporated into formycin after conversion to glutamate (or a-keto-glutarate) via the cycle. It is also suggested that glutamate is incorporated into formycin through a pathway other than that of degradation to 7-amino-n-butyrate.
In the biosynthesis of minimycin, a C-riboside antibiotic, ISONO and SUHADOLNIK reported that the distribution of 14C in this antibiotic favored a seven-carbon sugar or an eight-carbon branched sugar as the carbon skeleton for the ribosyl moiety and carbons-4 and -5 (probably carbons-4, -5 and -6) of the oxazine moiety. To explain the synthetic mechanism, they proposed a pathway involving glycolytic and hexose monophosphate oxidative pathway.") If formycin occurs via the proposed pathway, the following presumptions may be possible with regard to the experiments described in this paper. Tables 4 and 5 are consistent with presumptions 1, 2 and 4. It is, however, in conflict with presumption 3 that, as shown in Table 4 ,14C from [1-14C]glucose was incorporated into carbon-1' and carbon(s)-2' to -5' of formycin at a ratio of approximately 1: 3. As one of the causes of the low values for percent incorporation of 14C from [U-14C]ribose into formycin, a low rate of uptake of ribose into mycelia was considered to be reasonable. The ratio of the rate of uptake of ribose to that of uptake of glucose was confirmed to be lower than one-thirtieth under the conditions of the replacement culture (data are not shown). These results, when considered with those described in the text, indicate that, although the possibility of formycin biosynthesis via the proposed pathway whereby minimycin occurs is difficult to be ruled out entirely, the possibility of the biosynthesis from ribose and such precursors for the chromophore moiety of formycin as lysine, glutamate and so on still seem likely. In any event, the more detailed studies on biosynthesis of the ribose moiety and the chromophore moiety, especially on carbon-3, are needed.
The inhibition of formycin formation by DFA-4 or pyrazofurin are shown in Table 5 suggesting that these compounds are not the precursors for the biosynthesis of formycin. In previous work, both the conversion of formycin B to formycin in replacement culture and the activity of formycin B aminating enzyme(s) were confirmed to be inhibited by DFA-4.15) These results led us to estimate that formycin B may be accumulated in the presence of DFA-4. Experimentally, however, neither formycin B nor formycin was accumulated even when DFA-4 was added at the concentration of 10 mm indicating the possibility that, in addition to the inhibition by DFA-4 of formycin aminating enzyme(s), this compound inhibits the other step(s) of the biosynthesis of formycin.
